Brief reportEffectiveness of sirolimus-eluting stent implantation for recurrent in-stent restenosis after brachytherapy
References (13)
- et al.
Coronary in-stent restenosiscurrent status and future strategies
J Am Coll Cardiol
(2002) - et al.
Late total occlusion after intracoronary brachytherapy for patients with in-stent restenosis
J Am Coll Cardiol
(2000) - et al.
Sirolimus-eluting stent for treatment of complex in-stent restenosisthe first clinical experience
J Am Coll Cardiol
(2003) - et al.
Radioactive stents delay but do not prevent in-stent neointimal hyperplasia
Circulation
(2001) - et al.
Late coronary occlusion after intracoronary brachytherapy
Circulation
(1999) - et al.
Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents
Circulation
(2000)
Cited by (53)
Coronary stents: Current status
2010, Journal of the American College of CardiologyCitation Excerpt :Several studies have compared the performance of DES with brachytherapy in patients with BMS ISR. All studies, ranging from nonrandomized pilot studies to the large randomized SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) study and the TAXUS V ISR study (PES vs. brachytherapy), which individually enrolled ∼400 patients, have shown a consistent benefit with treatment using DES (SES or PES) compared with brachytherapy (389–395). Of note, at long-term follow-up in the TAXUS V ISR study, a greater absolute difference in TLR was seen at 2-year follow-up in favor of PES (9-month ΔTLR 7.6% vs. 24-month ΔTLR 11.5%), without any compromise on safety (392).
Optical coherence tomography patterns of stent restenosis
2009, The American Heart JournalCitation Excerpt :This high-resolution imaging technique was able to evaluate the hyperplastic tissue in great detail. Interestingly, the tissue showed variation in structure, backscatter, and composition that were widely missed by IVUS in the past.17 In our study population, OCT was able to visualize details of the lumen shape and content and a wide range of components with different optical properties in the restenotic tissue.
Treatment with Drug-Eluting Stents
2007, Cardiovascular Therapeutics: A Companion to Braunwald's Heart DiseaseTreatment with drug-eluting stents
2006, Cardiovascular Therapeutics - A Companion to Braunwald's Heart Disease: Expert Consult - Online and PrintPredictors of outcome after sirolimus-eluting stent implantation for complex in-stent restenosis
2005, American Journal of Cardiology